CA
NZ
UK
AU
IND
US
BioLife Solutions (NASDAQ:BLFS), a supplier of products that help preserve cells and tissues for cell and gene therapy developers, is leaving the S&P SmallCap 600 because it is being acquired by Repligen (NASDAQ:RGEN). S&P Dow Jones Indices said Freshworks (NASDAQ:FRSH), the customer-service and IT …
Bruker (NASDAQ:BRKR), the maker of high-end scientific instruments such as mass spectrometers, nuclear magnetic resonance systems and X-ray tools used by research labs and drug companies, slid on Tuesday, October 6, and traded around $59.71. That made it one of the notable decliners in …
Fortrea Holdings (NASDAQ:FTRE), which runs clinical trials and provides drug-development services for pharmaceutical and biotech companies, rocketed on Tuesday, October 6, and traded around $23.32. The move made it one of the strongest gainers in the S&P SmallCap 600.
Azenta (NASDAQ:AZTA), which provides sample storage, sample management and genomic services to drug developers and research institutions, jumped on Tuesday, October 6, and traded around $46.19. The move made it one of the notable gainers in the S&P SmallCap 600.
● Cigna closed at $274.37 on Tuesday, October 6, up $3.08 or 1.14%, its third straight daily gain, beating the S&P 500's 0.58% rise.
● Oscar Health closed at $32.38 on Tuesday, October 6, down 0.12%, onVolumeof about 3.4 million shares after a 4.78% jump on October 5.
UnitedHealth Group (NYSE:UNH), the largest US health insurer and a member of the Dow Jones Industrial Average, slipped on Tuesday, October 6, closing lower. An earlier intraday reading had shown the stock slightly higher, but it gave up that gain as the session wore …
Option Care Health (NASDAQ:OPCH) was one of the biggest gainers in the S&P MidCap 400 on Tuesday, October 6, 2026. The shares rocketed to around $31, after drug distributor McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to acquire the company for $32.05 a …
Option Care Health (NASDAQ:OPCH) rocketed on the S&P MidCap 400 on Tuesday, October 6, 2026, after McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to take the company private. The buyers will pay $32.05 a share in cash, valuing the company at about $5.8 …
Revvity (NYSE:RVTY) slid on Tuesday, landing among the weaker members of the S&P 500 despite a fresh vote of confidence from Wall Street. William Blair initiated coverage of the company with an Outperform rating on the same day. No other company-specific catalyst was found …
Please wait processing your request...